These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 19839917)
1. Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients. Leong C; Ngeow J; Tan I; Quek R; Tao M; Loh Y; Tan HC; Lim ST Acta Oncol; 2010; 49(2):257-9. PubMed ID: 19839917 [No Abstract] [Full Text] [Related]
2. Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease. Amadori S; Papa G; Anselmo AP; Fidani P; Mandelli F; Biagini C Cancer Treat Rep; 1983 Jun; 67(6):603-4. PubMed ID: 6190561 [No Abstract] [Full Text] [Related]
3. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine). Lipton JH; Gospodarowicz M; Reingold S Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133 [TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease and the risk of acute leukemia in successfully treated patients. Valagussa P; Bonadonna G Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571 [No Abstract] [Full Text] [Related]
5. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages? Andrieu JM; Colonna P J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234 [No Abstract] [Full Text] [Related]
6. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131 [TBL] [Abstract][Full Text] [Related]
7. A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy. Katsumata R; Sagawa R; Akechi T; Shinagawa Y; Nakaaki S; Inagaki A; Okuyama T; Akazawa T; Furukawa TA Jpn J Clin Oncol; 2010 Apr; 40(4):365-8. PubMed ID: 20026458 [TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. Hoskin PJ; Lowry L; Horwich A; Jack A; Mead B; Hancock BW; Smith P; Qian W; Patrick P; Popova B; Pettitt A; Cunningham D; Pettengell R; Sweetenham J; Linch D; Johnson PW J Clin Oncol; 2009 Nov; 27(32):5390-6. PubMed ID: 19738111 [TBL] [Abstract][Full Text] [Related]
9. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663 [TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease. Brusamolino E; Lazzarino M; Morra E; Inverardi D; Merante S; Castelli G; Canevari A; Dornini G; Bernasconi C Haematologica; 1989; 74(2):173-9. PubMed ID: 2473013 [TBL] [Abstract][Full Text] [Related]
12. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages? Diehl V; Fuchs M; Transfus Apher Sci; 2007 Aug; 37(1):37-41. PubMed ID: 17714996 [TBL] [Abstract][Full Text] [Related]
13. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. Williamson PJ; de Berker D Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077 [No Abstract] [Full Text] [Related]
14. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. Martinelli G; Cocorocchio E; Peccatori F; Zucca E; Saletti PC; Calabrese L; Pastano R; Pruneri G; Mazzetta C; Ghielmini M; Cavalli F Br J Haematol; 2004 Jun; 125(5):584-9. PubMed ID: 15147373 [TBL] [Abstract][Full Text] [Related]
15. [Results of the treatment of Hodgkin's disease stage III and IV using the ABVD and BACOP programs]. Leszko B; Słomkowski M; Przybyszewska M; Apel D; Pawelski S Acta Haematol Pol; 1986; 17(3-4):81-90. PubMed ID: 2438894 [No Abstract] [Full Text] [Related]
16. Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients. Kalin M; Kristinsson SY; Cherif H; Lebbad M; Björkholm M Ann Hematol; 2010 May; 89(5):523-5. PubMed ID: 19768459 [No Abstract] [Full Text] [Related]
17. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute. Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748 [TBL] [Abstract][Full Text] [Related]